Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5
作者:Andrew S. Felts、Sam A. Saleh、Uyen Le、Alice L. Rodriguez、C. David Weaver、P. Jeffrey Conn、Craig W. Lindsley、Kyle A. Emmitte
DOI:10.1016/j.bmcl.2009.10.024
日期:2009.12
A high-throughput cell-based screen identified a series of 6-substituted-4-anilinoquinazolines as noncompetitive antagonists of metabotropic glutamate receptor 5 (mGlu(5)). This Letter describes the SAR of this series and the profile of selected compounds in selectivity and radioligand binding assays. (C) 2009 Elsevier Ltd. All rights reserved.
CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES SUCH AS TAUOPATHIES
申请人:Electrophoretics Limited
公开号:US20160354375A1
公开(公告)日:2016-12-08
The invention relates to pharmaceutical compositions comprising casein kinase 1 delta (CK1δ) and to the use of said inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease.
Targeting the Water Network in Cyclin G‐Associated Kinase (GAK) with 4‐Anilino‐quin(az)oline Inhibitors
作者:Christopher R. M. Asquith、Graham J. Tizzard、James M. Bennett、Carrow I. Wells、Jonathan M. Elkins、Timothy M. Willson、Antti Poso、Tuomo Laitinen
DOI:10.1002/cmdc.202000150
日期:2020.7.3
Waternetworks within kinaseinhibitor design and more widely within drug discovery are generally poorly understood. The successful targeting of these networks prospectively has great promise for all facets of inhibitor design, including potency and selectivity for the target. Herein, we describe the design and testing of a targeted library of 4‐anilinoquin(az)olines for use as inhibitors of cyclin